Sam Kongsamut
No más puestos en curso
Perfil
Dr. Sam Kongsamut is Executive Director-Pharmacology Division at Neurotrope, Inc.
Dr. Kongsamut was previously employed as a Director-External Innovation by Sanofi.
He received his doctorate degree from The University of Chicago.
Antiguos cargos conocidos de Sam Kongsamut.
| Empresas | Cargo | Fin |
|---|---|---|
| SANOFI | Corporate Officer/Principal | - |
| NEUROTROPE, INC. | Corporate Officer/Principal | - |
Formación de Sam Kongsamut.
| The University of Chicago | Doctorate Degree |
Experiencias
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Empresas relacionadas
| Empresas cotizadas | 1 |
|---|---|
| SANOFI | Health Technology |
| Empresas privadas | 1 |
|---|---|
Neurotrope, Inc.
 Neurotrope, Inc. Pharmaceuticals: MajorHealth Technology Neurotrope, Inc. is a biopharmaceutical company, which engages in the pre-clinical and clinical development of its product candidates. The company focuses on developing a product platform based upon a drug candidate called bryostatin for the treatment of Alzheimer's disease. It also develops bryostatin for other neurodegenerative or cognitive diseases and dysfunctions, such as Fragile X and Niemann-Pick Type C. The company was founded on January 11, 2011 and is headquartered in New York, NY. | Health Technology |
- Bolsa de valores
- Insiders
- Sam Kongsamut
